Weight Loss
15
 min read

Does Fatty Liver Affect Sperm Quality and Male Fertility?

Written by
Bolt Pharmacy
Published on
3/3/2026

Non-alcoholic fatty liver disease (NAFLD) affects approximately 25–30% of the UK population and is increasingly recognised as a potential factor in male fertility problems. Emerging research suggests that fatty liver may be associated with reduced sperm quality, altered hormone levels, and impaired reproductive function, though the relationship is complex and often linked to shared metabolic risk factors such as obesity and insulin resistance. Understanding how liver health influences sperm parameters and testosterone metabolism is important for men experiencing fertility difficulties. This article examines the evidence connecting fatty liver disease to male fertility and outlines practical steps to improve both liver health and reproductive outcomes.

Summary: Fatty liver disease (NAFLD) is associated with reduced sperm quality and altered testosterone levels, though the relationship is complex and often linked to shared metabolic factors such as obesity and insulin resistance rather than liver disease alone.

  • NAFLD is linked to reduced sperm concentration, motility, and morphology, though causality has not been proven.
  • Men with fatty liver often have lower testosterone and higher oestrogen due to disrupted liver hormone metabolism.
  • Oxidative stress and chronic inflammation associated with NAFLD may damage sperm DNA and impair sperm production.
  • Weight loss of 7–10% and lifestyle modifications can reverse fatty liver and may improve fertility outcomes.
  • Normal liver enzyme blood tests do not exclude NAFLD or advanced liver fibrosis; risk scoring is essential.
  • Seek medical advice if trying to conceive for 12 months without success, or earlier if NAFLD or other risk factors are present.

Am I eligible for weight loss injections?

60-second quiz
Eligibility checker

Find out whether you might be eligible!

Answer a few quick questions to see whether you may be suitable for prescription weight loss injections (like Wegovy® or Mounjaro®).

  • No commitment — just a quick suitability check
  • Takes about 1 minute to complete

Understanding Fatty Liver Disease and Male Fertility

Non-alcoholic fatty liver disease (NAFLD) has emerged as one of the most common chronic liver conditions in the UK, affecting approximately 25–30% of the general population, though estimates vary by population and diagnostic method. This condition occurs when excess fat accumulates in liver cells in individuals who consume little to no alcohol. The spectrum ranges from simple steatosis (fat accumulation) to non-alcoholic steatohepatitis (NASH), which involves inflammation and potential liver damage. You may also encounter the newer term metabolic dysfunction-associated steatotic liver disease (MASLD), which reflects the same condition.

Recent research has begun to explore the relationship between NAFLD and male reproductive health, revealing potential connections that extend beyond liver function alone. The liver plays a crucial role in metabolic regulation, hormone metabolism, and the production of proteins essential for overall health. When liver function becomes compromised due to fatty infiltration, these processes may be disrupted, potentially affecting multiple organ systems including the reproductive system.

Key risk factors for NAFLD include:

  • Obesity and excess abdominal fat

  • Type 2 diabetes or insulin resistance

  • Metabolic syndrome

  • High cholesterol or triglycerides

  • Sedentary lifestyle

Male fertility depends on a complex interplay of hormonal balance, sperm production, and overall metabolic health. Given that NAFLD is closely associated with metabolic dysfunction, obesity, and insulin resistance—conditions that can independently affect reproductive function—understanding the potential impact of fatty liver on sperm health has become increasingly relevant for men experiencing fertility difficulties. The relationship between liver health and fertility is multifaceted, involving hormonal pathways, oxidative stress, and systemic inflammation that may collectively influence sperm parameters and reproductive potential.

It is important to note that NAFLD can be present even when liver blood tests (liver enzymes such as ALT and AST) are normal. Normal liver function tests do not exclude fatty liver disease or, in some cases, more advanced liver fibrosis. If you have risk factors for NAFLD, discuss appropriate assessment with your GP, as outlined in NICE guidance (NG49).

Does Fatty Liver Affect Sperm Quality and Count?

Emerging evidence suggests that NAFLD may be associated with reduced sperm quality, though the relationship is complex and influenced by multiple factors. Several studies have identified associations between fatty liver disease and reduced sperm parameters, including decreased sperm concentration, motility (movement), and morphology (shape). However, it is important to note that there is no established direct causative relationship, and much of the observed association may be explained by shared metabolic risk factors such as obesity, insulin resistance, and lifestyle factors. Other confounders—including medications, varicocele, and environmental exposures—also play a role.

The mechanisms through which NAFLD might be linked to sperm quality involve several pathways. Firstly, the condition is associated with increased oxidative stress—an imbalance between harmful free radicals and protective antioxidants in the body. Sperm cells are particularly vulnerable to oxidative damage due to their high content of polyunsaturated fatty acids in their membranes. This oxidative stress may damage sperm DNA, impair motility, and reduce overall sperm viability, though the clinical significance of these findings requires further research.

Secondly, NAFLD is characterised by chronic low-grade inflammation, with elevated levels of inflammatory markers such as C-reactive protein and various cytokines. This systemic inflammation may disrupt the delicate environment required for optimal sperm production in the testes (spermatogenesis). Studies have shown that men with NAFLD often have higher levels of inflammatory markers, which correlate with poorer semen parameters, though causality has not been proven.

Observed associations with sperm parameters may include:

  • Reduced sperm concentration (oligozoospermia)

  • Decreased progressive motility

  • Abnormal sperm morphology

  • Increased DNA fragmentation (evidence limited)

It is crucial to recognise that many men with NAFLD also present with obesity, insulin resistance, and other metabolic conditions that independently affect fertility. Therefore, whilst fatty liver may contribute to reduced sperm quality, it is often part of a broader metabolic picture rather than an isolated cause of male infertility. Semen analysis should be interpreted according to World Health Organization (WHO) standards, with at least two samples collected after 2–7 days of abstinence if initial results are abnormal or borderline.

How Liver Health Impacts Testosterone and Reproductive Function

The liver plays a pivotal role in sex hormone metabolism, particularly in regulating testosterone and oestrogen levels in men. In healthy individuals, the liver metabolises and clears excess oestrogen whilst maintaining appropriate testosterone levels. However, when liver function is compromised by fatty infiltration and inflammation, this delicate hormonal balance can be disrupted, with significant implications for male reproductive health.

Men with NAFLD frequently exhibit altered sex hormone profiles, most notably reduced total and free testosterone levels and relatively elevated oestrogen. This occurs through several mechanisms. The liver produces sex hormone-binding globulin (SHBG), a protein that binds to testosterone in the blood. In NAFLD, particularly when associated with insulin resistance, SHBG production may be reduced, leading to changes in the ratio of bound to free testosterone. Additionally, increased aromatase activity in adipose tissue (fat cells) converts testosterone to oestradiol (a form of oestrogen), further skewing the hormonal balance.

Hormonal changes associated with NAFLD include:

  • Reduced total and free testosterone

  • Decreased SHBG levels

  • Relatively increased oestrogen (oestradiol)

  • Altered luteinising hormone (LH) and follicle-stimulating hormone (FSH) levels

Low testosterone has well-established effects on male fertility and sexual function. It can impair spermatogenesis, reduce libido, cause erectile dysfunction, and decrease overall sperm production. The hypothalamic-pituitary-gonadal (HPG) axis, which regulates reproductive hormone production, may become dysregulated in the context of metabolic dysfunction and fatty liver disease. This disruption can create a cycle where hormonal imbalances further perpetuate metabolic problems, which in turn worsen liver health and reproductive function.

If hormonal assessment is needed, your GP will typically arrange a morning blood test (ideally around 9 am) to measure total testosterone, along with SHBG, LH, and FSH. Abnormal results should be confirmed with a repeat test. It is critical to note that exogenous testosterone replacement therapy markedly suppresses sperm production and is generally avoided in men who are trying to conceive. If testosterone deficiency is confirmed and fertility is a concern, seek specialist advice, as alternative treatments (such as gonadotrophins) may be considered. Addressing liver health through lifestyle changes may have beneficial effects on hormonal balance and, consequently, on fertility potential.

Managing Fatty Liver to Improve Fertility Outcomes

The cornerstone of NAFLD management involves lifestyle modifications that can simultaneously improve liver health and enhance fertility potential. Fortunately, the liver has remarkable regenerative capacity, and fatty liver disease is often reversible with appropriate interventions. Weight loss of 7–10% of body weight has been shown to significantly reduce liver fat content and improve metabolic parameters, which may positively impact reproductive function. For individuals with obesity, evidence-based weight management options—including specialist weight management services, GLP-1 receptor agonist medications (where NICE criteria are met), and bariatric surgery in selected cases—may be appropriate; discuss these with your GP.

Dietary modifications form a crucial component of management. The Mediterranean diet, rich in vegetables, fruits, whole grains, legumes, nuts, and olive oil, with moderate fish consumption and limited red meat, has demonstrated benefits for both liver health and fertility. Reducing intake of refined carbohydrates, added sugars, and saturated fats can improve insulin sensitivity and reduce hepatic fat accumulation. Regarding alcohol, UK guidance advises keeping within low-risk limits (no more than 14 units per week, spread over at least three days). However, abstinence is recommended if you have steatohepatitis (NASH) or advanced liver fibrosis, or if advised by your specialist.

Physical activity is equally important. The UK Chief Medical Officers recommend at least 150 minutes of moderate-intensity aerobic activity per week, combined with muscle-strengthening activities on two or more days. Exercise improves insulin sensitivity, reduces liver fat, promotes weight loss, and has been shown to improve testosterone levels and sperm parameters in overweight men. Even without significant weight loss, regular physical activity can reduce liver fat content by 20–30%.

NAFLD risk stratification and monitoring are essential. NICE guidance (NG49) recommends that your GP calculate a risk score (such as FIB-4 or the NAFLD Fibrosis Score) to assess the likelihood of advanced liver fibrosis. If the score is indeterminate or high, you may be offered an Enhanced Liver Fibrosis (ELF) blood test or referred to a liver specialist. Liver ultrasound can detect fat but may miss fibrosis, so risk scores and specialist tests are important. Regular monitoring of liver function tests and, where appropriate, liver imaging can track progress and guide ongoing management.

Medical management may be appropriate in certain cases. It is important to understand that:

  • Metformin is used to optimise blood sugar control in people with type 2 diabetes, but it is not a treatment for NAFLD itself.

  • Statins are safe and effective for managing high cholesterol in people with NAFLD when clinically indicated.

  • Vitamin E may be considered in non-diabetic adults with biopsy-proven NASH, after discussion of potential risks and benefits with a specialist.

  • Pioglitazone may be considered in people with biopsy-proven NASH, after a careful risk–benefit discussion with a specialist.

For men concerned about fertility, antioxidant supplementation (such as vitamin C, vitamin E, selenium, and coenzyme Q10) is sometimes discussed, but evidence for effectiveness is mixed and inconsistent. NICE guidance on fertility (CG156) does not routinely recommend antioxidants; consider them only under specialist advice. Smoking cessation is crucial, as smoking compounds oxidative stress and worsens both liver disease and sperm quality.

If you experience side effects from any medicines or supplements, you can report them via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk.

When to Seek Medical Advice About Fertility Concerns

Men should consider seeking medical advice if they have been trying to conceive with their partner for 12 months or more without success. However, earlier consultation is warranted if there are known risk factors for infertility or underlying health conditions such as NAFLD. NICE guidance (CG156) recommends considering earlier referral if the woman is aged 36 or over, or if there is a known cause of infertility or predisposing factor in either partner. Given the potential impact of fatty liver disease on reproductive health, men diagnosed with NAFLD who are planning to start a family should discuss fertility implications with their GP or hepatologist.

Specific circumstances requiring medical review include:

  • Difficulty conceiving after 12 months of regular unprotected intercourse (or earlier if the woman is aged 36 or over)

  • Known diagnosis of NAFLD or abnormal liver function tests

  • Symptoms of low testosterone (reduced libido, erectile dysfunction, fatigue, loss of muscle mass)

  • Significant obesity (BMI ≥30 kg/m²) or metabolic syndrome

  • History of testicular problems, infections, or surgery

  • Occupational or environmental exposures to toxins

Your GP can arrange initial investigations, which typically include semen analysis to assess sperm count, motility, and morphology. Semen samples should be collected after 2–7 days of abstinence, and at least two samples (ideally three months apart) are recommended if initial results are abnormal or borderline, in line with WHO standards. Blood tests may evaluate liver function (ALT, AST, GGT), metabolic parameters (fasting glucose, HbA1c, lipid profile), and reproductive hormones (total testosterone measured in the morning, ideally around 9 am, along with LH, FSH, prolactin, and SHBG). Remember that normal liver enzyme levels do not exclude NAFLD or advanced fibrosis. If NAFLD is suspected but not yet confirmed, your GP will calculate a fibrosis risk score (FIB-4 or NAFLD Fibrosis Score) and may arrange liver ultrasound or an ELF blood test, or refer you to a liver specialist if indicated.

Referral to specialist services may be appropriate depending on findings. This might include hepatology for advanced liver disease management, endocrinology for significant hormonal abnormalities, or reproductive medicine/urology for comprehensive fertility assessment. Many NHS trusts offer integrated metabolic and reproductive health services that can address both liver health and fertility concerns concurrently.

Seek urgent medical attention by calling 999 or going to A&E if you experience:

  • Severe abdominal pain, especially with fever or signs of systemic illness

  • Jaundice (yellowing of skin or eyes)

  • Vomiting blood or passing black, tarry stools

  • Acute confusion or altered mental state

  • Unexplained severe fatigue, easy bruising, or swelling of the abdomen or legs

Early intervention offers the best opportunity to reverse fatty liver disease and optimise fertility potential. With appropriate lifestyle modifications, medical management where needed, and specialist support when indicated, many men can improve both their liver health and reproductive function, enhancing their chances of successful conception.

Frequently Asked Questions

Can fatty liver disease lower my sperm count?

Fatty liver disease (NAFLD) is associated with reduced sperm concentration and quality, though a direct causative link has not been proven. The observed association is likely due to shared metabolic factors such as obesity, insulin resistance, and chronic inflammation, which independently affect sperm production and may collectively reduce sperm count and motility.

How does fatty liver affect testosterone levels in men?

Men with fatty liver disease often have reduced total and free testosterone levels and relatively elevated oestrogen due to disrupted liver hormone metabolism. The liver produces sex hormone-binding globulin (SHBG), which may be reduced in NAFLD, and increased aromatase activity in fat tissue converts testosterone to oestrogen, further imbalancing hormones critical for sperm production and sexual function.

Will losing weight improve my sperm quality if I have a fatty liver?

Weight loss of 7–10% of body weight can significantly reduce liver fat and improve metabolic parameters, which may positively impact sperm quality and testosterone levels. Regular physical activity and a Mediterranean-style diet have been shown to improve insulin sensitivity, reduce liver inflammation, and enhance sperm parameters in overweight men, even before significant weight loss occurs.

Can I take medication for fatty liver whilst trying to conceive?

Lifestyle modification is the primary treatment for fatty liver disease, but certain medications may be appropriate in specific cases after specialist consultation. Statins are safe for managing cholesterol in NAFLD, whilst vitamin E or pioglitazone may be considered for biopsy-proven NASH under specialist guidance; however, exogenous testosterone replacement therapy markedly suppresses sperm production and should be avoided when trying to conceive.

What is the difference between fatty liver and more serious liver disease?

Fatty liver disease exists on a spectrum from simple steatosis (fat accumulation alone) to non-alcoholic steatohepatitis (NASH), which involves inflammation and potential liver damage, and may progress to fibrosis or cirrhosis. Normal liver enzyme blood tests do not exclude NAFLD or advanced fibrosis, so your GP should calculate a fibrosis risk score (FIB-4 or NAFLD Fibrosis Score) and arrange further assessment if indicated, as outlined in NICE guidance.

When should I see my GP about fertility problems related to fatty liver?

Seek medical advice if you have been trying to conceive for 12 months without success, or earlier if your partner is aged 36 or over, or if you have known NAFLD or metabolic risk factors. Your GP can arrange semen analysis, hormone blood tests (including morning testosterone), liver function tests, and fibrosis risk scoring, and refer you to hepatology or fertility specialists if needed for comprehensive assessment and management.


Disclaimer & Editorial Standards

The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.

The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.

Heading 1

Heading 2

Heading 3

Heading 4

Heading 5
Heading 6

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Block quote

Ordered list

  1. Item 1
  2. Item 2
  3. Item 3

Unordered list

  • Item A
  • Item B
  • Item C

Text link

Bold text

Emphasis

Superscript

Subscript

Book a discovery call

and discuss your eligibility for the Fella Program

Book your free call